CapEval Pharma

Ert, French consultancy firm providing pharmaceutical services from discovery to market entry, headquartered in France.

Here are key aspects of the company:

• Industries: The company operates within the pharmaceutical sector, specifically supporting early pre-clinical to clinical development stages.
• Innovation: CapEval demonstrates its expertise by resolving complex biological challenges, such as identifying inappropriate animal species for toxicity studies or proving that observed effects in rats were not relevant to humans.
• Operations: Services include implementing derisking cardiac strategies during due diligence and optimizing exposure routes to mitigate genotox effects found in metabolite studies.

Founded in 2010 by Dr Olivier Loget DVM, Ert CapEval Pharma has established a track record of transforming potential project stoppages into successful developments through targeted scientific consultancy.